Cardinal Health (CAH) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$254.2B

Revenue (quarter)

$63.7B

Revenue growth (year over year)

+5.84%

Gross profit (trailing twelve months)

$9.8B

Gross margin

3.84%

Net income (trailing twelve months)

$1.7B

Net income (quarter)

$400.0M

Net income growth (year over year)

+64.61%

Net margin

0.67%

Return on equity

—

EPS (trailing twelve months)

$7.27

Book value per share

−$12.37

P/E (trailing twelve months)

32.39

Price to book

—

Debt to assets

104.75%

Payout ratio

28.25%

Dividend yield

0.87%

Company profile

Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

• Is Cardinal Health (CAH) profitable?

  Yes. Cardinal Health earned $1.7B in net income over the trailing twelve months, a net margin of 0.67%.

• How much revenue does Cardinal Health (CAH) make?

  Cardinal Health generated $254.2B in revenue over the trailing twelve months, up 5.84% year over year.

• What is CAH's P/E ratio?

  Cardinal Health trades at 32.4 times trailing twelve-month earnings, on an EPS of $7.27.

• How do I buy stock in Cardinal Health (CAH)?

  CAH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.